Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying
Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying
Perspective Therapeutics 和其他三只价格低于 1 美元的股票业
The Dow Jones index closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周一收盘小幅走高。当内部人士买入或卖出股票时，这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将其视为其整体投资或交易决策中的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多，请查看 本辛加的内幕交易 平台。
Tharimmune
Tharmunmune
- The Trade: Tharimmune, Inc. (NASDAQ:THAR) CEO Randy Milby acquired a total of 29,000 shares an average price of $0.50. To acquire these shares, it cost around $14,587.
- What's Happening: Tharimmune recently announced topline data with TH104, its lead candidate for moderate-to-severe pruritus in chronic liver disease patients.
- What Tharimmune Does: Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases.
- 交易：Tharimmune, Inc.（纳斯达克股票代码：THAR）首席执行官兰迪·米尔比 共收购了 29,000 股股票 平均价格为0.50美元。收购这些股票的成本约为14,587美元。
- 发生了什么：Tharimmune 最近公布了 TH104 的头条数据，是慢性肝病患者中度至重度瘙痒症的主要候选药物。
- Tharimmune 的作用：Tharimmune Inc. 是一家生物技术公司，正在开发针对罕见免疫、炎症和肿瘤疾病的候选治疗产品组合。
Perspective Therapeutics
透视疗法
- The Trade: Perspective Therapeutics, Inc. (NASDAQ:CATX) Director Lori A Woods acquired a total of 185,200 shares at an average price of $0.27. To acquire these shares, it cost around $49,989.
- What's Happening: Perspective Therapeutics recently announced it agreed to fully divest its brachytherapy business.
- What Perspective Therapeutics Does: Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body.
- 交易：Perspective Therapeutics, Inc.（纳斯达克股票代码：CATX）董事洛里·伍兹 共收购了 185,200 股股票 平均价格为0.27美元。收购这些股票的成本约为49,989美元。
- 发生了什么：Perspective Therapeutics最近宣布，它同意完全剥离其近距离放射治疗业务。
- Perspective Therapeutics做什么：Perspective Therapeutics Inc是一家医疗技术和放射性药物公司，致力于开创全身癌症的各种治疗应用。
Check This Out: Aware And 3 Other Stocks Under $2 Insiders Are Buying
看看这个： Aware 还有其他 3 只低于 2 美元的股票业内人士正在买入
SHF Holdings
SHF Holdings
- The Trade: SHF Holdings, Inc. (NASDAQ:SHFS) CEO Sundie Seefried acquired a total of 24,700 shares at an average price of $0.96. The insider spent around $23,737 to buy those shares. The company's Director also bought 15,000 shares of the company.
- What's Happening: On Nov. 14, SHF Hldgs posted a loss for the third quarter.
- What SHF Holdings Does: SHF Holdings Inc is a financial services provider to cannabis-related businesses.
- 交易：SHF Holdings, Inc.（纳斯达克股票代码：SHFS）首席执行官桑迪·塞弗里德 共收购了 24,700 股股票 平均价格为0.96美元。内幕人士花费了大约23,737美元购买了这些股票。该公司的董事还购买了公司的15,000股股票。
- 发生了什么：11月14日，SHF Hldgs公布了第三季度的亏损。
- SHF Holdings做什么：SHF Holdings Inc是大麻相关企业的金融服务提供商。
Dalrada Financial
达尔拉达金融
- The Trade: Dalrada Financial Corporation (OTC:DFCO) CEO Brian Bonar acquired a total of 9,000 shares at an average price of $0.29. The insider spent around $2,616 to buy those shares.
- What's Happening: The company's stock jumped 26% over the past six months.
- What Dalrada Financial Does: Dalrada Financial Corp is a United States-based company engaged in providing financial, insurance, benefit, and business process outsourcing products and services to companies.
- 交易：达拉达金融公司（场外交易代码：DFCO）首席执行官布莱恩·博纳 共收购9,000股股份 平均价格为0.29美元。内幕人士花费了约2616美元购买这些股票。
- 发生了什么：该公司的股票在过去六个月中上涨了26％。
- Dalrada Financial做什么：Dalrada Financial Corp是一家总部位于美国的公司，致力于为公司提供财务、保险、福利和业务流程外包产品和服务。
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道